Intellectual Property
Oct. 18, 2017
Allergan eye drug patents invalidated
Drugmaker Allergan LLC, already under fire from members of Congress for transferring its patents covering an eye drug to a Native American tribe, got more bad news this week from a Texas federal judge who invalidated them.
Drugmaker Allergan LLC, already under fire from members of Congress for transferring its patents covering an eye drug to a Native American tribe, got more bad news this week from a Texas federal judge who invalidated them.
U.S. District Judge William C. Bryson of the Eastern District of Texas ruled Monday against the plaintiff over the patents for Restasis.
He also ruled, in a separate order, that ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In